J Mesić

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

Miljenko V. Pilepich, Kathryn Winter, Madhu J. John et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 774 citations

Urology, Radiation Medicine, Radiation Therapy +7

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

Miljenko V. Pilepich, Richard Caplan, Roger W. Byhardt et al. · Journal of Clinical Oncology · 1997 · 609 citations

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

C.A. Lawton, Kathryn Winter, Kevin Murray et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 377 citations

Urology, Radiation Therapy, Medicine +6

Megavoltage irradiation of epithelial tumors of the nasopharynx

J Mesić, Gilbert H. Fletcher, Helmuth Goepfert · International Journal of Radiation Oncology*Biology*Physics · 1981 · 265 citations

Radiation Therapy, Medicine, Megavoltage Irradiation +6

p53 Status and Prognosis of Locally Advanced Prostatic Adenocarcinoma: a Study Based on RTOG 8610

David J. Grignon, F. H. Sarkar, J.D. Forman et al. · JNCI Journal of the National Cancer Institute · 1997 · 184 citations · Full text